Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMEREN CORPAEE · Entity 3150 | Director | January 03, 2025 | January 07, 2025 |
| EDGEWELL PERSONAL CARE CoEPC · Entity 4787 | Director | February 06, 2025 | February 10, 2025 |
| ENERGIZER HOLDINGS, INC.ENR · Entity 4736 | Director | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMEREN CORP
Report date January 03, 2025 · Filed January 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 60,196 |
Reported balance
After 2025-01-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-01-03 · Grant · Acquired 1,911 · Balance 60,196 F1: Director compensation. F2: Amount includes a total of 1927 shares acquired during the first through fourth quarters of 2024 through reinvested dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Director compensation.
F2: Amount includes a total of 1927 shares acquired during the first through fourth quarters of 2024 through reinvested dividends.
EDGEWELL PERSONAL CARE Co
Report date February 06, 2025 · Filed February 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Equivalents 2-6-2025SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,999 |
Reported balance
After 2025-02-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-06 · Grant · Acquired 4,999 · Balance 4,999 F1: Restricted stock equivalents convert into sharers of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock equivalents convert into sharers of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.
ENERGIZER HOLDINGS, INC.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Unit Award 1/2/2026SEC Table II · derivative / convertible security | Direct | 7,534 |
Reported balance
After 2026-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 7,534 · Balance 7,534 F1: Restricted Stock Units convert into common stock on a one-for-one basis. F2: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units convert into common stock on a one-for-one basis.
F2: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hanesbrands Inc.
Report date December 01, 2025 · Filed December 01, 2025
Section 16 reporting ended · disclosed 2025-12-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2025-12-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-01 · Disposition to issuer · Disposed 73,682 · Balance 18,630 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of August 13, 2025 (the "Merger Agreement"), by and among the Issuer, Gildan Activewear Inc. ("Gildan"), Galaxy Merger Sub 2, Inc., a direct wholly owned subsidiary of Gildan ("Second Gildan Merger Sub"), Galaxy Merger Sub 1, Inc., a direct wholly owned subsidiary of Second Gildan Merger Sub ("First Gildan Merger Sub"), Helios Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Hanesbrands Holdco"), and Helios Merger Sub, Inc., a direct wholly owned subsidiary of Hanesbrands Holdco. Pursuant to the Merger Agreement, each share of the Issuer's common stock ("Hanesbrands Common Stock") reported on this Form 4 was ultimately converted into the right to receive (a) 0.102 common shares of Gildan ("Gildan Common Shares") and (b) $0.80 in cash, without interest. Row 2 · 2025-12-01 · Disposition to issuer · Disposed 18,630 · Balance 0 F2: Pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each, a "Hanesbrands RSU"), whether vested or unvested, was ultimately converted into a Gildan restricted stock unit (each, a "Gildan RSU"). The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time (as defined in the Merger Agreement) by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. The "Equity Award Exchange Ratio" means the sum of (a) 0.102 and (b) the quotient, rounded to two decimal places, F3: (Continued from Footnote 2) obtained by dividing (i) $0.80 by (ii) the average of the volume weighted averages of the trading prices of Gildan Common Shares on the New York Stock Exchange on each of the 20 consecutive trading days ending on (and including) the trading day that is two trading days prior to the date on which the closing of the transactions pursuant to the Merger Agreement occurs. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-12-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-01 · Disposition to issuer · Disposed 167,608 · Balance 0 F4: Represents (x) equity retainers or long-term incentive payments comprised of an award that is subject to a deferral election pursuant to a deferral plan of the Issuer (each, a "Deferred Hanesbrands RSU") and (y) Hanesbrands RSUs corresponding to a cash deferral invested in a stock equivalent account under a deferral plan of the Issuer (each, a "Stock Equivalent Hanesbrands RSU"), as applicable. Pursuant to the Merger Agreement, each outstanding Deferred Hanesbrands RSU and Stock Equivalent Hanesbrands RSU was ultimately converted into a Gildan RSU. The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Deferred Hanesbrands RSU or Stock Equivalent Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of August 13, 2025 (the "Merger Agreement"), by and among the Issuer, Gildan Activewear Inc. ("Gildan"), Galaxy Merger Sub 2, Inc., a direct wholly owned subsidiary of Gildan ("Second Gildan Merger Sub"), Galaxy Merger Sub 1, Inc., a direct wholly owned subsidiary of Second Gildan Merger Sub ("First Gildan Merger Sub"), Helios Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Hanesbrands Holdco"), and Helios Merger Sub, Inc., a direct wholly owned subsidiary of Hanesbrands Holdco. Pursuant to the Merger Agreement, each share of the Issuer's common stock ("Hanesbrands Common Stock") reported on this Form 4 was ultimately converted into the right to receive (a) 0.102 common shares of Gildan ("Gildan Common Shares") and (b) $0.80 in cash, without interest.
F2: Pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each, a "Hanesbrands RSU"), whether vested or unvested, was ultimately converted into a Gildan restricted stock unit (each, a "Gildan RSU"). The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time (as defined in the Merger Agreement) by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. The "Equity Award Exchange Ratio" means the sum of (a) 0.102 and (b) the quotient, rounded to two decimal places,
F3: (Continued from Footnote 2) obtained by dividing (i) $0.80 by (ii) the average of the volume weighted averages of the trading prices of Gildan Common Shares on the New York Stock Exchange on each of the 20 consecutive trading days ending on (and including) the trading day that is two trading days prior to the date on which the closing of the transactions pursuant to the Merger Agreement occurs.
F4: Represents (x) equity retainers or long-term incentive payments comprised of an award that is subject to a deferral election pursuant to a deferral plan of the Issuer (each, a "Deferred Hanesbrands RSU") and (y) Hanesbrands RSUs corresponding to a cash deferral invested in a stock equivalent account under a deferral plan of the Issuer (each, a "Stock Equivalent Hanesbrands RSU"), as applicable. Pursuant to the Merger Agreement, each outstanding Deferred Hanesbrands RSU and Stock Equivalent Hanesbrands RSU was ultimately converted into a Gildan RSU. The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Deferred Hanesbrands RSU or Stock Equivalent Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 5, 2026 16:31 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Unit Award 1/2/2026 · Derivative | 7,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001632790-26-000017 · wk-form4_1767648692.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,534 Underlying: Common Stock · 7,534 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. F2 · derivative.expiration_date: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 10:02 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerPhantom Stock · Derivative | 167,608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-303330 · ownership.xml · derivative · entry 3 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 167,608 shares Expires not disclosed F4 · derivative.exercise_price: Represents (x) equity retainers or long-term incentive payments comprised of an award that is subject to a deferral election pursuant to a deferral plan of the Issuer (each, a "Deferred Hanesbrands RSU") and (y) Hanesbrands RSUs corresponding to a cash deferral invested in a stock equivalent account under a deferral plan of the Issuer (each, a "Stock Equivalent Hanesbrands RSU"), as applicable. Pursuant to the Merger Agreement, each outstanding Deferred Hanesbrands RSU and Stock Equivalent Hanesbrands RSU was ultimately converted into a Gildan RSU. The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Deferred Hanesbrands RSU or Stock Equivalent Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. F4 · price: Represents (x) equity retainers or long-term incentive payments comprised of an award that is subject to a deferral election pursuant to a deferral plan of the Issuer (each, a "Deferred Hanesbrands RSU") and (y) Hanesbrands RSUs corresponding to a cash deferral invested in a stock equivalent account under a deferral plan of the Issuer (each, a "Stock Equivalent Hanesbrands RSU"), as applicable. Pursuant to the Merger Agreement, each outstanding Deferred Hanesbrands RSU and Stock Equivalent Hanesbrands RSU was ultimately converted into a Gildan RSU. The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Deferred Hanesbrands RSU or Stock Equivalent Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. F4 · derivative.exercise_date: Represents (x) equity retainers or long-term incentive payments comprised of an award that is subject to a deferral election pursuant to a deferral plan of the Issuer (each, a "Deferred Hanesbrands RSU") and (y) Hanesbrands RSUs corresponding to a cash deferral invested in a stock equivalent account under a deferral plan of the Issuer (each, a "Stock Equivalent Hanesbrands RSU"), as applicable. Pursuant to the Merger Agreement, each outstanding Deferred Hanesbrands RSU and Stock Equivalent Hanesbrands RSU was ultimately converted into a Gildan RSU. The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Deferred Hanesbrands RSU or Stock Equivalent Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. F4 · derivative.expiration_date: Represents (x) equity retainers or long-term incentive payments comprised of an award that is subject to a deferral election pursuant to a deferral plan of the Issuer (each, a "Deferred Hanesbrands RSU") and (y) Hanesbrands RSUs corresponding to a cash deferral invested in a stock equivalent account under a deferral plan of the Issuer (each, a "Stock Equivalent Hanesbrands RSU"), as applicable. Pursuant to the Merger Agreement, each outstanding Deferred Hanesbrands RSU and Stock Equivalent Hanesbrands RSU was ultimately converted into a Gildan RSU. The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Deferred Hanesbrands RSU or Stock Equivalent Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 10:02 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerCommon Stock | 18,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-303330 · ownership.xml · nonDerivative · entry 2 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Merger Agreement, each outstanding restricted stock unit of the Issuer (each, a "Hanesbrands RSU"), whether vested or unvested, was ultimately converted into a Gildan restricted stock unit (each, a "Gildan RSU"). The number of Gildan Common Shares subject to each such Gildan RSU was determined by multiplying the number of shares of Hanesbrands Common Stock subject to such Hanesbrands RSU immediately prior to the First Gildan Merger Effective Time (as defined in the Merger Agreement) by the Equity Award Exchange Ratio, rounding down to the nearest whole number of Gildan Common Shares. The "Equity Award Exchange Ratio" means the sum of (a) 0.102 and (b) the quotient, rounded to two decimal places, F3 · price: (Continued from Footnote 2) obtained by dividing (i) $0.80 by (ii) the average of the volume weighted averages of the trading prices of Gildan Common Shares on the New York Stock Exchange on each of the 20 consecutive trading days ending on (and including) the trading day that is two trading days prior to the date on which the closing of the transactions pursuant to the Merger Agreement occurs. Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 10:02 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerCommon Stock | 73,682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-303330 · ownership.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,630 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of August 13, 2025 (the "Merger Agreement"), by and among the Issuer, Gildan Activewear Inc. ("Gildan"), Galaxy Merger Sub 2, Inc., a direct wholly owned subsidiary of Gildan ("Second Gildan Merger Sub"), Galaxy Merger Sub 1, Inc., a direct wholly owned subsidiary of Second Gildan Merger Sub ("First Gildan Merger Sub"), Helios Holdco, Inc., a direct wholly owned subsidiary of the Issuer ("Hanesbrands Holdco"), and Helios Merger Sub, Inc., a direct wholly owned subsidiary of Hanesbrands Holdco. Pursuant to the Merger Agreement, each share of the Issuer's common stock ("Hanesbrands Common Stock") reported on this Form 4 was ultimately converted into the right to receive (a) 0.102 common shares of Gildan ("Gildan Common Shares") and (b) $0.80 in cash, without interest. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 14:36 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents 2-6-2025 · Derivative | 4,999 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004528 · wk-form4_1739198212.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,999 Underlying: Common Stock · 4,999 shares Expires not disclosed F1 · derivative.expiration_date: Restricted stock equivalents convert into sharers of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 17:59 UTC | Hanesbrands Inc. HBI · Entity 72407 | Tax withholdingCommon Stock | 13,843 | $8.07 | $111,713.01 |
DisclosureSEC source: 0000950170-25-012519 · ownership.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,769 F1 · kind: Represents shares of common stock withheld to pay taxes upon vesting of restricted stock units originally granted to the Reporting Person on January 29, 2024. The number of shares withheld was determined on January 30, 2025 based on the closing price of Hanesbrands Inc. common stock on January 29, 2025. F1 · price: Represents shares of common stock withheld to pay taxes upon vesting of restricted stock units originally granted to the Reporting Person on January 29, 2024. The number of shares withheld was determined on January 30, 2025 based on the closing price of Hanesbrands Inc. common stock on January 29, 2025. Read SEC document |
| January 28, 2025 Filed Feb 4, 2025 21:25 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantCommon Stock | 18,630 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-014072 · ownership.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,399 F1 · shares: Consists of restricted stock units that upon vesting on the first anniversary of the grant date are settled on a one-for-one basis in shares of common stock.. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 21:35 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-25-000024 · wk-form4_1736285730.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,196 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 1927 shares acquired during the first through fourth quarters of 2024 through reinvested dividends. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 16:12 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Unit Award 1/2/2025 · Derivative | 4,335 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001632790-25-000014 · wk-form4_1735938731.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,335 Underlying: Common Stock · 4,335 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. F2 · derivative.expiration_date: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 18:45 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 2-1-2024 · Derivative | 3,853 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-003249 · wk-form4_1707158710.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,853 Underlying: Common Stock · 3,853 shares Expires not disclosed F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 20:38 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantCommon Stock | 33,477 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-009572 · ownership.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,612 F1 · shares: Consists of restricted stock units that upon vesting on the first anniversary of the grant date are settled on a one-for-one basis in shares of common stock. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 19:52 UTC | Hanesbrands Inc. HBI · Entity 72407 | Tax withholdingCommon Stock | 7,431 | $4.29 | $31,878.99 |
DisclosureSEC source: 0000950170-24-009074 · ownership.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,135 F1 · kind: Represents shares of common stock withheld to pay taxes upon vesting of restricted stock units originally granted to the Reporting Person on January 23, 2023. The number of shares withheld was determined on January 26, 2024 based on the closing price of Hanesbrands Inc. common stock on January 23, 2024. F1 · price: Represents shares of common stock withheld to pay taxes upon vesting of restricted stock units originally granted to the Reporting Person on January 23, 2023. The number of shares withheld was determined on January 26, 2024 based on the closing price of Hanesbrands Inc. common stock on January 23, 2024. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 23:04 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 2,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-24-000021 · wk-form4_1704495840.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,357 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 1712 shares acquired during the first through fourth quarters of 2023 through reinvested dividends. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:45 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Unit Award 1/2/2024 · Derivative | 4,709 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001632790-24-000004 · edgardoc.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,709 Underlying: Common Stock · 4,709 shares Expires not disclosed F1 · derivative.exercise_price: RSEs and RSUs convert into common stock on a one-for-one basis. F1 · price: RSEs and RSUs convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. F2 · derivative.expiration_date: Annual Restricted Stock Unit (RSU) Award valued at $150,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 13:42 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/03/2023 · Derivative | 3,318 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-007407 · doc4.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,318 Underlying: Common Stock · 3,318 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 19:57 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantPhantom Stock · Derivative | 9,515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-002806 · doc4.xml · derivative · entry 3 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,608 Underlying: Common Stock · 9,515 shares Expires not disclosed F2 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F3 · derivative.exercise_price: 1-for-1 F1 · price: Represents a deferral by the Reporting Person of 9,515 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on January 24, 2022. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). F4 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F4 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F5 · balance_after: Includes phantom stock units acquired through deemed dividend reinvestment. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 19:57 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerCommon Stock | 9,515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-002806 · doc4.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,566 F1 · price: Represents a deferral by the Reporting Person of 9,515 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on January 24, 2022. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 16:43 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantCommon Stock | 18,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002658 · doc4.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,081 F1 · shares: Consists of restricted stock units that upon vesting on the first anniversary of the grant date are settled on a one-for-one basis in shares of common stock. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:36 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-23-000023 · wf-form4_167295456617772.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,618 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 1338 shares acquired during the first through fourth quarters of 2022 through reinvested dividends. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 18:13 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Unit Award 1/3/2023 · Derivative | 4,244 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001632790-23-000008 · edgardoc.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,244 Underlying: Common Stock · 4,244 shares Expires not disclosed F1 · derivative.exercise_price: RSEs and RSUs convert into common stock on a one-for-one basis. F1 · price: RSEs and RSUs convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Annual Restricted Stock Unit (RSU) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. F2 · derivative.expiration_date: Annual Restricted Stock Unit (RSU) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 17:17 UTC | Hanesbrands Inc. HBI · Entity 72407 | PurchaseCommon Stock | 2,000 | $9.11 | $18,220.00 |
DisclosureSEC source: 0000899243-22-030811 · doc4.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares Owned by Trust Disclosed balance after: 26,913 Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 21:25 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/04/2022 · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007448 · doc4.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 Underlying: Common Stock · 3,375 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 16:48 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantPhantom Stock · Derivative | 9,603 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-22-000060 · wf-form4_164340649095881.xml · derivative · entry 3 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,515 Underlying: Common Stock · 9,603 shares Expires not disclosed F2 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F3 · derivative.exercise_price: 1-for-1 F1 · price: Represents a deferral by the Reporting Person of 9,603 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on January 26, 2021. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). F4 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F4 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F5 · balance_after: Includes phantom stock units acquired through deemed dividend reinvestment. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 16:48 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerCommon Stock | 9,603 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-22-000060 · wf-form4_164340649095881.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,316 F1 · price: Represents a deferral by the Reporting Person of 9,603 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on January 26, 2021. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). Read SEC document |
| January 24, 2022 Filed Jan 26, 2022 17:27 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantCommon Stock | 9,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001359841-22-000031 · wf-form4_164323601203921.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,919 F1 · shares: Consists of restricted stock units that upon vesting on the first anniversary of the grant date are settled on a one-for-one basis in shares of common stock. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:00 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-22-000014 · wf-form4_164142358959731.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,584 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 1252 shares acquired during the first through fourth quarters of 2021 through reinvested dividends. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 18:44 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Unit Award 1/3/2022 · Derivative | 3,561 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001632790-22-000013 · edgardoc.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,561 Underlying: Common Stock · 3,561 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Annual Restricted Stock Unit (RSU) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. F2 · derivative.expiration_date: Annual Restricted Stock Unit (RSU) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 16:44 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/04/2021 · Derivative | 3,799 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008422 · doc4.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,799 Underlying: Common Stock · 3,799 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 16:09 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantPhantom Stock · Derivative | 10,541 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-21-000049 · wf-form4_161221375273636.xml · derivative · entry 3 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,495 Underlying: Common Stock · 10,541 shares Expires not disclosed F2 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F3 · derivative.exercise_price: 1-for-1 F1 · price: Represents a deferral by the Reporting Person of 10,541 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on January 28, 2020. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Company Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). F4 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F4 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. Read SEC document |
| January 28, 2021 Filed Feb 1, 2021 16:09 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerCommon Stock | 10,541 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-21-000049 · wf-form4_161221375273636.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,404 F1 · price: Represents a deferral by the Reporting Person of 10,541 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on January 28, 2020. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Company Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 16:29 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantCommon Stock | 9,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001359841-21-000037 · wf-form4_161186934491474.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,945 F1 · shares: Consists of restricted stock units that upon vesting on the first anniversary of the grant date are settled on a one-for-one basis in shares of common stock. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 17:19 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Unit Award 1/4/2021 · Derivative | 3,433 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001632790-21-000008 · edgardoc.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,433 Underlying: Common Stock · 3,433 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Annual Restricted Stock Unit (RSU) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. F2 · derivative.expiration_date: Annual Restricted Stock Unit (RSU) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSUs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| January 02, 2021 Filed Jan 6, 2021 00:23 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-21-000023 · wf-form4_160989260905310.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,638 F1 · shares: Director compensation issued as Stock Units under the Ameren Corporation Deferred Compensation Plan for Members of the Board of Directors. F2 · balance_after: Amount includes 1173 shares acquired during 2020 through reinvested dividends. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 16:53 UTC | Hanesbrands Inc. HBI · Entity 72407 | Exercise / conversionPhantom Stock · Derivative | 287 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-20-000110 · wf-form4_160755078412242.xml · derivative · entry 7 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,954 Underlying: Common Stock · 287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F4 · derivative.exercise_price: 1-for-1 F7 · price: Represents a distribution to the Reporting Person of 287 shares of Hanesbrands Inc. common stock that had been contributed to the HBI Stock Fund in the Plan. F5 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F5 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 16:53 UTC | Hanesbrands Inc. HBI · Entity 72407 | Exercise / conversionPhantom Stock · Derivative | 27,123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-20-000110 · wf-form4_160755078412242.xml · derivative · entry 6 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,241 Underlying: Common Stock · 27,123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F4 · derivative.exercise_price: 1-for-1 F1 · price: Represents a distribution to the Reporting Person of 27,123 shares of Hanesbrands Inc. common stock that had been contributed to a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Deferred Compensation Plan (the "Plan"). F5 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F5 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. board of directors. F6 · balance_after: Includes acquisitions of 1,918.038, 1,679.381, 1,431.905 and 1,588.868 phantom stock units acquired through deemed dividend reinvestment on March 10, 2020, June 9, 2020, September 1, 2020 and December 1, 2020, respectively. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 16:53 UTC | Hanesbrands Inc. HBI · Entity 72407 | Tax withholdingCommon Stock | 122 | $14.39 | $1,755.58 |
DisclosureSEC source: 0001359841-20-000110 · wf-form4_160755078412242.xml · nonDerivative · entry 4 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,342 F2 · kind: Represents shares of common stock withheld to pay taxes upon the distribution of Hanesbrands Inc. common stock from the Plan. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 16:53 UTC | Hanesbrands Inc. HBI · Entity 72407 | Exercise / conversionCommon Stock | 287 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-20-000110 · wf-form4_160755078412242.xml · nonDerivative · entry 3 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Represents shares of common stock withheld to pay taxes upon the distribution of Hanesbrands Inc. common stock from the Plan. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 16:53 UTC | Hanesbrands Inc. HBI · Entity 72407 | Tax withholdingCommon Stock | 11,487 | $14.20 | $163,115.40 |
DisclosureSEC source: 0001359841-20-000110 · wf-form4_160755078412242.xml · nonDerivative · entry 2 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,177 F2 · kind: Represents shares of common stock withheld to pay taxes upon the distribution of Hanesbrands Inc. common stock from the Plan. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 16:53 UTC | Hanesbrands Inc. HBI · Entity 72407 | Exercise / conversionCommon Stock | 27,123 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-20-000110 · wf-form4_160755078412242.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents a distribution to the Reporting Person of 27,123 shares of Hanesbrands Inc. common stock that had been contributed to a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Deferred Compensation Plan (the "Plan"). Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 14:49 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/06/2020 · Derivative | 3,944 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007780 · doc4.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,944 Underlying: Common Stock · 3,944 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 28, 2020 Filed Feb 19, 2020 16:46 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantCommon Stock | 10,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001359841-20-000029 · wf-form4_158214877202477.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,541 F1 · shares: Consists of restricted stock units that upon vesting on the first anniversary of the grant date are settled on a one-for-one basis in shares of common stock. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 14:31 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-20-000046 · wf-form4_157832108472093.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,607 F1 · shares: Director compensation. F2 · balance_after: Amount includes 1,036 shares acquired during 2019 through reinvested dividends. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 17:02 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Equivalent 1/2/2020 · Derivative | 2,987 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001632790-20-000006 · edgardoc.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,987 Underlying: Common Stock · 2,987 shares Expires not disclosed F1 · derivative.exercise_date: Annual Restricted Stock Equivalent (RSE) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSEs vest and convert upon death, termination of service on the Board and Change of Control. F1 · derivative.expiration_date: Annual Restricted Stock Equivalent (RSE) Award valued at $145,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSEs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 16:00 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantPhantom Stock · Derivative | 9,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-19-000097 · wf-form4_157627082464967.xml · derivative · entry 3 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,747 Underlying: Common Stock · 9,409 shares Expires not disclosed F2 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F3 · derivative.exercise_price: 1-for-1 F1 · price: Represents a deferral by the Reporting Person of 9,409 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on December 11, 2018. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). F4 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. Board of Directors. F4 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. Board of Directors. F5 · balance_after: Includes acquisitions of 1,100.49, 1,251.61, 1,459.29 and 1,376.33 phantom stock units acquired through deemed dividend reinvestment on March 12, 2019, June 4, 2019, September 4, 2019 and December 3, 2019, respectively. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 16:00 UTC | Hanesbrands Inc. HBI · Entity 72407 | Disposition to issuerCommon Stock | 9,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-19-000097 · wf-form4_157627082464967.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents a deferral by the Reporting Person of 9,409 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on December 11, 2018. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). Read SEC document |
| May 28, 2019 Filed May 29, 2019 14:44 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 1,000 | $30.50 | $30,503.00 |
DisclosureSEC source: 0001209191-19-033135 · doc4.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: The reporting person purchased these shares in multiple transactions with a purchase price range of $30.48 to $30.52. The Company will share with any shareholder or the Securities and Exchange Commission the detail of these purchases upon written request to the Company. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 20:48 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalent 02/01/2019 · Derivative | 3,156 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-007281 · doc4.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,156 Underlying: Common Stock · 3,156 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. F1 · derivative.expiration_date: Restricted stock equivalents convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:07 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-19-000050 · edgar.xml · nonDerivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,664 F1 · shares: Director compensation issued as Stock Units under the Ameren Corporation Deferred Compensation Plan for Members of the Board of Directors. F2 · balance_after: Amount includes a total of 1,142 shares acquired during the first through fourth quarters of 2018 through reinvested dividends at prices ranging from $53.84 to $70.19 per share. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 17:00 UTC | ENERGIZER HOLDINGS, INC. ENR · Entity 4736 | GrantRestricted Stock Equivalent 1/2/2019 · Derivative | 2,460 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001632790-19-000008 · edgardoc.xml · derivative · entry 1 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,460 Underlying: Common Stock · 2,460 shares Expires not disclosed F1 · derivative.exercise_date: Annual Restricted Stock Equivalent (RSE) Award valued at $110,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSEs vest and convert upon death, termination of service on the Board and Change of Control. F1 · derivative.expiration_date: Annual Restricted Stock Equivalent (RSE) Award valued at $110,000 vests and converts into shares one year from date of grant unless Reporting Person elects to defer conversion until retirement. All RSEs vest and convert upon death, termination of service on the Board and Change of Control. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 16:19 UTC | Hanesbrands Inc. HBI · Entity 72407 | GrantPhantom Stock · Derivative | 6,683 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001359841-18-000129 · wf-form4_154473593481291.xml · derivative · entry 4 Johnson James C · CIK 0001325453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,151 Underlying: Common Stock · 6,683 shares Expires not disclosed F3 · security: Represents an HBI Stock Fund balance under the Plan. Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock. F4 · derivative.exercise_price: 1-for-1 F2 · price: Represents a deferral by the Reporting Person of 6,683 shares of Hanesbrands Inc. common stock upon the vesting of restricted stock units granted to the Reporting Person on December 12, 2017. The amount deferred was deemed to be invested in a stock equivalent account (the "HBI Stock Fund") in the Hanesbrands Inc. Non-Employee Director Deferred Compensation Plan (the "Plan"). F5 · derivative.exercise_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. Board of Directors. F5 · derivative.expiration_date: Balances in the HBI Stock Fund are settled on a share-for-share basis in shares of Hanesbrands Inc. common stock (i) with respect to deferrals prior to January 1, 2008, at the time specified by the Reporting Person at the time of the Reporting Person's deferral election, which in no case shall be prior to the January 1 following the first anniversary of the date the deferral election is made and (ii) with respect to deferrals on or after January 1, 2008, on the earlier of the fifth anniversary of the date of the deferral or the Reporting Person's separation from service as a member of the Hanesbrands Inc. Board of Directors. F6 · balance_after: Includes acquisitions of 905.91, 957.33, 1,019.01 and 1,187.19 phantom stock units acquired through deemed dividend reinvestment on March 13, 2018, June 5, 2018, September 5, 2018 and December 4, 2018, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.